151 related articles for article (PubMed ID: 8014878)
21. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
[TBL] [Abstract][Full Text] [Related]
22. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.
Palmantier R; Surette ME; Sanchez A; Braquet P; Borgeat P
Lab Invest; 1994 May; 70(5):696-704. PubMed ID: 8196365
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation.
Rao TS; Currie JL; Shaffer AF; Isakson PC
Inflammation; 1993 Dec; 17(6):723-41. PubMed ID: 8112831
[TBL] [Abstract][Full Text] [Related]
24. Involvement of LTB4 in zymosan-induced joint nociception in mice: participation of neutrophils and PGE2.
Guerrero AT; Verri WA; Cunha TM; Silva TA; Schivo IR; Dal-Secco D; Canetti C; Rocha FA; Parada CA; Cunha FQ; Ferreira SH
J Leukoc Biol; 2008 Jan; 83(1):122-30. PubMed ID: 17913976
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene B4 receptor (BLT-1) modulates neutrophil influx into the peritoneum but not the lung and liver during surgically induced bacterial peritonitis in mice.
Scott MJ; Cheadle WG; Hoth JJ; Peyton JC; Subbarao K; Shao WH; Haribabu B
Clin Diagn Lab Immunol; 2004 Sep; 11(5):936-41. PubMed ID: 15358656
[TBL] [Abstract][Full Text] [Related]
26. Cysteinyl leukotrienes and leukotriene B mediate vasoconstriction to arginine vasopressin in rat basilar artery.
Trandafir CC; Nishihashi T; Ji X; Wang A; Kurahashi K
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1027-33. PubMed ID: 16445567
[TBL] [Abstract][Full Text] [Related]
27. The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation.
Fretland DJ; Levin S; Tsai BS; Djurić SW; Widomski DL; Zemaitis JM; Shone RL; Bauer RF
Agents Actions; 1989 Jun; 27(3-4):395-7. PubMed ID: 2552769
[TBL] [Abstract][Full Text] [Related]
28. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
[TBL] [Abstract][Full Text] [Related]
29. Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils.
Kolaczkowska E; Arnold B; Opdenakker G
Immunobiology; 2008; 213(2):109-24. PubMed ID: 18241695
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2.
Doherty NS; Poubelle P; Borgeat P; Beaver TH; Westrich GL; Schrader NL
Prostaglandins; 1985 Nov; 30(5):769-89. PubMed ID: 3001831
[TBL] [Abstract][Full Text] [Related]
31. [Effect of TSP-2 antibody against a single epitope of mouse Toll-like receptor 2 extracellular domain on zymosan A-induced peritonitis in mice].
Yang CL; Zhao WZ; Huang EP; Luo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1521-4. PubMed ID: 19726281
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of 5-lipoxygenase products by electrospray mass spectrometry: effect of ethanol on zymosan-stimulated production of 5-lipoxygenase products by human neutrophils.
Wheelan P; Murphy RC
Anal Biochem; 1997 Jan; 244(1):110-5. PubMed ID: 9025916
[TBL] [Abstract][Full Text] [Related]
33. Acute inflammation in peritoneal dialysis: experimental studies in rats. Characterization of regulatory mechanisms.
Bazargani F
Swed Dent J Suppl; 2005; (171):1-57, i. PubMed ID: 15847249
[TBL] [Abstract][Full Text] [Related]
34. Reverse-phase high-performance liquid chromatography analysis of arachidonic acid metabolites in plasma after stimulation of whole blood ex vivo.
Surette ME; Odeimat A; Palmantier R; Marleau S; Poubelle PE; Borgeat P
Anal Biochem; 1994 Feb; 216(2):392-400. PubMed ID: 8179194
[TBL] [Abstract][Full Text] [Related]
35. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA.
Jeon SG; Moon HG; Kim YS; Choi JP; Shin TS; Hong SW; Tae YM; Kim SH; Zhu Z; Gho YS; Kim YK
Clin Exp Allergy; 2009 Jun; 39(6):908-17. PubMed ID: 19260872
[TBL] [Abstract][Full Text] [Related]
36. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice.
Kolaczkowska E; Seljelid R; Plytycz B
J Leukoc Biol; 2001 Jan; 69(1):33-42. PubMed ID: 11200065
[TBL] [Abstract][Full Text] [Related]
37. Discovery of (2-fluoro-benzyl)-(2-methyl-2-phenethyl-2H-chromen-6-yl)-amine (KRH-102140) as an orally active 5-lipoxygenase inhibitor with activity in murine inflammation models.
Cho YS; Song JS; Huh JY; Kim CH; Gong YD; Cheon HG
Pharmacology; 2011; 87(1-2):49-55. PubMed ID: 21212714
[TBL] [Abstract][Full Text] [Related]
38. Thioglycollate peritonitis in mice lacking C5, 5-lipoxygenase, or p47(phox): complement, leukotrienes, and reactive oxidants in acute inflammation.
Segal BH; Kuhns DB; Ding L; Gallin JI; Holland SM
J Leukoc Biol; 2002 Mar; 71(3):410-6. PubMed ID: 11867678
[TBL] [Abstract][Full Text] [Related]
39. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
